Myocardial Infarction

• FDA approval · 2007-10-22
  FDA Approved: PLAVIX — Supplemental Application (Sanofi-Aventis U.S. LLC)

  FDA approves a supplemental application for Plavix (clopidogrel) submitted by Sanofi-Aventis U.S. LLC.

• FDA approval · 2007-09-20
  FDA Approved: PLAVIX — Supplemental Application (Sanofi-Aventis U.S. LLC)

  FDA approves a supplemental application for PLAVIX (clopidogrel) from Sanofi-Aventis U.S. LLC.

• FDA approval · 2007-09-05
  FDA Approved: CARVEDILOL — Original Application (Dr. Reddy's Laboratories Limited)

  FDA approved Carvedilol on an original application by Dr. Reddy's Laboratories Limited (generic carvedilol).

• FDA approval · 2007-07-16
  FDA Approved: COREG CR — Supplemental Application (Waylis Therapeutics LLC)

  The FDA approved a supplemental application for COREG CR (carvedilol phosphate) submitted by Waylis Therapeutics LLC.

• FDA approval · 2007-05-30
  FDA Approved: METOPROLOL TARTRATE — Original Application (Hikma Pharmaceuticals USA Inc.)

  The FDA approved Hikma Pharmaceuticals USA Inc.'s original ANDA for metoprolol tartrate, a generic beta-blocker used to treat cardiovascular…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2007-03-01
  FDA Approved: ATENOLOL — Supplemental Application (Zydus Lifesciences Limited)

  The FDA approved a supplemental application for Atenolol from Zydus Lifesciences Limited under an ANDA. The action approves changes to the g…

• FDA approval · 2007-02-13
  FDA Approved: LISINOPRIL — Supplemental Application (Camber Pharmaceuticals, Inc.)

  FDA supplemental approval for Camber Pharmaceuticals' lisinopril generic under ANDA075903. Lisinopril is used to treat hypertension, heart f…

• FDA approval · 2007-02-06
  FDA Approved: LISINOPRIL — Supplemental Application (Aurobindo Pharma Limited)

  FDA approves a supplemental application for lisinopril from Aurobindo Pharma Limited, authorizing a generic lisinopril product under an ANDA…

• FDA approval · 2007-01-30
  FDA Approved: LISINOPRIL — Supplemental Application (Quallent Pharmaceuticals Health LLC)

  The FDA approved a supplemental application for lisinopril filed by Quallent Pharmaceuticals Health LLC.

• FDA approval · 2007-01-27
  FDA Approved: ATENOLOL — Supplemental Application (Zydus Lifesciences Limited)

  FDA approved a supplemental application for Atenolol submitted by Zydus Lifesciences Limited.

• FDA approval · 2006-12-27
  FDA Approved: ATENOLOL — Original Application (Ipca Laboratories Limited)

  FDA approved the original ANDA for Atenolol by Ipca Laboratories Limited, authorizing a generic atenolol product. Atenolol is used for condi…

• FDA approval · 2006-10-04
  FDA Approved: HEPARIN SODIUM — Supplemental Application (Civica, Inc.)

  The FDA approved Civica, Inc.'s supplemental application for Heparin Sodium. This action updates the product labeling as part of the NDA 017…

• FDA approval · 2006-09-13
  FDA Approved: ATENOLOL — Original Application (Rising Pharma Holdings, Inc.)

  FDA approved Atenolol as a generic under ANDA077443 from Rising Pharma Holdings, Inc. for the treatment of hypertension, angina pectoris, an…

• FDA approval · 2006-08-17
  FDA Approved: PLAVIX — Supplemental Application (Sanofi-Aventis U.S. LLC)

  FDA approved a supplemental application for Plavix (clopidogrel) submitted by Sanofi-Aventis U.S. LLC.

• FDA approval · 2006-08-08
  FDA Approved: LISINOPRIL — Supplemental Application (Quallent Pharmaceuticals Health LLC)

  FDA approved a supplemental application for lisinopril from Quallent Pharmaceuticals Health LLC.

• FDA approval · 2006-07-17
  FDA Approved: ATENOLOL — Supplemental Application (Zydus Lifesciences Limited)

  The FDA approved a supplemental application for Atenolol filed by Zydus Lifesciences Limited (ANDA 076900).

• FDA approval · 2006-07-03
  FDA Approved: LISINOPRIL — Supplemental Application (Camber Pharmaceuticals, Inc.)

  The FDA approved Camber Pharmaceuticals' supplemental application for lisinopril, authorizing the continued marketing of its lisinopril gene…

• FDA approval · 2006-06-20
  FDA Approved: QUINAPRIL — Original Application (BluePoint Laboratories)

  FDA approved the original ANDA for Quinapril from BluePoint Laboratories, establishing a generic version of the ACE inhibitor used to treat …

• FDA approval · 2006-06-08
  FDA Approved: LISINOPRIL — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.(780779901))

  The FDA issued approval for a supplemental application for lisinopril from Heritage Pharmaceuticals (Avet), authorizing marketing of a gener…

• FDA approval · 2006-05-04
  FDA Approved: TOPROL XL — Supplemental Application (Melinta Therapeutics, LLC)

  FDA approved a supplemental application for TOPROL XL (metoprolol succinate) sponsored by Melinta Therapeutics, LLC.